Company intelligence / Profile preview

Lerøy Seafood Group

Bergen, Vestland, Norway

Ownership: Private
Employees: ~6000
Development stage: Other

Overview

Lerøy Seafood Group is primarily a seafood corporation that has expanded into life sciences and biotechnology through its '100% Fish' initiative, which focuses on extracting high-value biomedical and nutritional compounds from fish byproducts. Notable clinical/commercial results include the launch of SalmoFer, a marine-derived iron supplement, and strategic investments in biotech firms like Salmonics to develop reagents for regenerative medicine and wound care using salmon blood.

Therapeutic areas: HematologyCardiovascularNeurologyDermatology
Modalities: ProteinSmall moleculeNutraceutical
Industry: Biotech

Partnerships

SalmonicsBellona FoundationNorwegian Seafood Research Fund (FHF)

Beyond the preview

Go deeper on Lerøy Seafood Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lerøy Seafood Group.

Explore the full profile